After participating in this educational activity, attendees should be able to:
1| Discuss current data on new HIV infections.
2| Discuss new options for HIV prevention in people at risk for HIV.
3| Update the learners on the approved medications for HIV prevention.


Daniel J. Skiest, MD

Faculty Disclosure

The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options.  Faculty or planner conflicts of interest are resolved before the educational activity.

Dr. Skiest (Planner)receives grant/research support from Glaxo SmithKline-VIIV.

None of the other members of the planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.

Session date: 
09/16/2020 - 1:00pm to 2:00pm EDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 BCIPE Instructional Hours

Please login or register to take this course.